MentionFox
Home › Stakes › Fold Holdings, Inc.
5%+ stakes · Schedule 13D and 13G

Fold Holdings, Inc.: 5%+ holders

Who has reported owning 5% or more of Fold Holdings, Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more3
Filings7
Latest filing2026-05-15

Fold Holdings, Inc. has 7 Schedule 13D or 13G filings on record since 2025-07-21. 3 holders' latest filing reports 5% or more of common stock, par value us$0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
Fulgur Frontier Capital LP37.5%18,100,406SCHEDULE 13D/A, 2026-03-172025-12-30
Jonathan Kirkwood12%5,817,700SCHEDULE 13D/A, 2026-03-032026-02-26
SZOP Opportunities I LLC9.9%5,361,529SCHEDULE 13G/A, 2026-02-172025-12-31
ATW Growth Opportunities SPV, LLC3.3%1,739,130SCHEDULE 13G/A, 2026-05-152026-03-31
Emerald ESG Sponsor, LLC0%0SCHEDULE 13G/A, 2025-07-212025-06-12

Purpose of Transaction (Item 4)

Jonathan Kirkwood

The Reporting Persons are filing this Schedule 13D/A to report a change in their respective beneficial ownership percentages of the shares of Common Stock. Ten31 Join the Fold LLC disposed of all 1,682,670 shares of Common Stock reported in the initial 13D filing on December 19, 2025, 144,311 of which were distributed to Jonathan Kirkwood in exchange for no consideration. Additionally, Dr. Kirkwood obtained beneficial ownership of 112,500 shares through a grant of restricted stock units on June 3, 2025. SATS Credit Fund, LP acquired 520,000 shares of Common Stock in a transaction with the Issuer on February 26, 2026 (as further described in Item 6), and 750,000 shares of Common Stock and 925,590 warrants to purchase shares of Common Stock on March 5, 2025. Dr. Kirkwood is a director of the Issuer. As such, he participates in the planning and decisions of the board of directors. Dr. Kirkwood may from time to time develop plans respecting, or propose changes in, the management, composition of the board of directors, operations, capital structure or business of the Issuer. Depending upon market conditions and other factors that Dr. Kirkwood deems material, he may purchase additional Common Stock or other securities of the Issuer in the open market, private transactions or from the Issuer, or may dispose of all or a portion of the Common Stock or other securities of the Issuer that he now own or may hereafter acquire. Except as described above, Dr. Kirkwood does not have any …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-03-03; the filing has the rest

Fulgur Frontier Capital LP

The Shares were acquired based on the belief that the Shares were undervalued and represented an attractive investment opportunity. Depending on overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of the Shares at prices that would make the purchase or sale of Common Stock desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Common Stock on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable. No Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D. This Amendment No. 1 is being filed solely to correct a ministerial error to the signature block of the original report.Item 4 of the SCHEDULE 13D/A filed 2026-03-17

Timeline

FiledHolderPercentFiling
2025-07-21Emerald ESG Sponsor, LLC0%SCHEDULE 13G/A
2025-08-08SZOP Opportunities I LLC9.9%SCHEDULE 13G
2026-02-17SZOP Opportunities I LLC9.9%SCHEDULE 13G/A
2026-03-03Jonathan Kirkwood12%SCHEDULE 13D/A
2026-03-12Fulgur Frontier Capital LP37.47%SCHEDULE 13D
2026-03-17Fulgur Frontier Capital LP37.5%SCHEDULE 13D/A
2026-05-15ATW Growth Opportunities SPV, LLC3.3%SCHEDULE 13G/A

Tools for this story

Each opens in a new tab, filled in for Fold Holdings, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/fold-holdings
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Fold Holdings, Inc. 5%+ holders: 3 at 5% or more, largest Fulgur Frontier Capital LP 37.5%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/fold-holdings